Background-Among patients with severe aortic stenosis (AS) and preserved ejection fraction
Introduction
Aortic stenosis (AS) is a serious health problem worldwide, with a dismal prognosis ensuing after the development of symptoms if untreated. While severe AS traditionally has been defined as an aortic valve area (AVA) < 1 cm 2 with a mean systolic Doppler gradient 40 mm Hg or a peak aortic velocity 4 m/s, in clinical practice, it is common for a patient to present with only one or two of these criteria 1 . Recently, there has been increased scrutiny of the syndrome of low-gradient (LG) severe AS and preserved ejection fraction (EF), as well as the entity termed "paradoxical low-flow (LF) LG severe AS" 2 . These conditions have importance not only for their illustration of the discordance that exists in AS severity criteria, but also because they may be associated with a poor prognosis 2 . When the triad of Doppler criteria is absent, and especially when the aortic valve gradient is low, patients may not be referred for aortic valve replacement (AVR).
It is well recognized that stroke volume is an important determinant of the aortic valve gradient. In patients with LG severe AS, stroke volume may be decreased due to a multitude of factors, including small body habitus, concentric remodeling with decreased ventricular cavity size, and elevated arterial impedance. To further define the hemodynamic features of severe AS, a recent flow-gradient classification has been proposed that incorporates both mean gradient and stroke volume 3 . The utility of examining stroke volume with this classification has been demonstrated in a relatively small study of patients with asymptomatic AS 4 . Whether stroke volume is predictive of outcome in large populations of patients with severe AS, including those with symptoms, remains unclear.
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Methods

Patients
The Mayo Clinic Institutional Review Board approved this study. Consecutive patients aged 18
years who underwent transthoracic echocardiography between January 1, 2006 and December 31, 2011 with the following criteria were enrolled: 1) AVA < 1.0 cm 2 ; 2) preserved left ventricular (LV) EF ( 50%); and 3) absence of prosthetic valves, complex congenital heart disease, supravalvular or subvalvular AS, hypertrophic cardiomyopathy, and other moderate or severe native valvular lesions. These criteria led to a final study population of 1,704 patients.
The medical record was reviewed for symptoms, co-morbidities, and laboratory data.
2-Dimensional and Doppler Echocardiography
Comprehensive 2-D and Doppler echocardiographic studies were performed on commercially available ultrasound equipment (Acuson Sequoia, Siemens Medical, Mountain View, CA; Vivid-7, GE Healthcare, Milwaukee, WI, and IE33, Phillips Healthcare, Andover, MA) in accordance with the American Society of Echocardiography guidelines 5, 6 . LV outflow tract diameter was measured in the parasternal long axis view in early systole from the point of aortic cusp insertion into the interventricular septum to the point of aortic cusp insertion into the intervalvular fibrosa.
LV outflow tract time velocity integral was measured using pulsed wave Doppler by placing the sample volume just below the region of flow convergence at approximately 5 mm apically from the aortic valve in the apical long axis view and aligning it parallel with blood flow. LV stroke volume was calculated using pulsed-wave Doppler as LV outflow tract area * LV outflow tract disease, supravalvular or subvalvular AS, hypertrophic cardiomyopathy, and oth he e er m m mod od oder er erat at ate e e or o evere native valvular lesions. These criteria led to a final study population of 1,704 patients. a
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velocity-time integral. For each study, a non-imaging probe was routinely used in multiple transducer positions in order to record the peak aortic jet velocity. For patients in sinus rhythm, 3 cardiac cycles were averaged; for atrial fibrillation, 10 cardiac cycles were averaged. Relative wall thickness was measured using the formula: (2 * posterior LV wall thickness)/LV dimension in end diastole. LV stroke volume was also estimated by the cube formula in order to examine a subgroup of patients with agreement between two methods of stroke volume calculation.
Afterload assessment
Ventricular afterload was assessed using the methods derived from echocardiography and systolic blood pressure. Valvuloarterial impedance (Zva), a measure of global LV afterload, was calculated using the following formula 7 : Zva (mm Hg/mL/m 2 ) = (mean systolic aortic valve Doppler gradient + systolic blood pressure) ÷ stroke volume index. Systemic arterial compliance (SAC), a measure of pulsatile arterial load, was measured using the formula: SAC (ml•mm Hg 
Clinical outcomes
Symptom onset, need for aortic valve intervention (valvuloplasty, transcatheter AVR, or surgical AVR), and vital status was determined using the medical record and data obtained from the Rochester Epidemiology Project and the National Death Index Data Registry. Records were manually reviewed and patients were classified as symptomatic if they reported symptoms of angina (typical chest pain), dyspnea that was believed to be related to aortic stenosis by their treating physician, or syncope. Heart failure was defined as a clinical history of congestive heart failure with evidence of pulmonary edema on chest radiograph that responded to diuretic calculated using the following formula 7 : Zva (mm Hg/mL/m 2 ) = (mean systolic c a a aor r rt tic c c va a valv lv lve e e Doppler gradient + systolic blood pressure) ÷ stroke volume index. Systemic arterial compliance S SAC AC AC), ) ), a a m m mea ea asu ure re re o of pulsatile arterial load, was me me m a asured using t the h h for or rm mu mula: SAC (ml•mm Hg In order to account for differences in likelihood of treatment with AVR, a propensity score was created by using a logistic regression model for AVR based on the following variables: age, sex, obesity, flow-gradient pattern, EF, AVA, mean gradient, peak velocity, Zva, SAC, hypertension, coronary artery disease, diabetes mellitus, atrial fibrillation, history of heart failure, prior transient ischemic attack or stroke, chronic obstructive pulmonary disease, prior coronary artery bypass grafting surgery, and symptomatic status. The probabilities from this model were then used as inverse probability weights in Cox proportional hazards regression to test for associations with outcomes of interest. In order to adjust for differences in baseline variables between groups, a multivariable model was constructed using stepwise selection for the outcome of mortality. Candidate variables included into the multivariable model included the same variables that were used to determine the propensity to receive AVR. Within the weighted proportional hazards framework, AVR and concomitant coronary artery bypass grafting were endpoints of interest were 1) all-cause mortality; 2) the combination of death or a a aor r rti ti t c c va va valv lv lve e e eplacement; and 3) all-cause mortality censored at AVR.
Statistical Analysis
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Results
Clinical and Hemodynamic Characteristics
A total of 14,656 patients with aortic stenosis underwent transthoracic echocardiography during the study period. There were 9,558 patients excluded for AVA > 1 cm 2 , 2,231 patients excluded for EF < 50%, and 1,156 patients excluded for 1 or more concomitant moderate valvular heart lesion. Two patients had supravalvular AS and 5 had subaortic stenosis due to tunnel/ridge and were excluded, leaving 1,704 included in the analysis. Tables 1 and 2 . The majority of patients were symptomatic, however, NF/LG patients were less symptomatic at study entry (53% vs. 74-80% in other groups, p<0.001). Events occurring during the followup period are listed in Table   3 .
The NF/LG group was characterized by a higher prevalence of females (58% vs. 27-42%, p<0.0001) and smaller body size (p<0.0001 for each group comparison), smaller LV outflow for EF < 50%, and 1,156 patients excluded for 1 or more concomitant moderat ate e e va va v lv v vul ul ular ar ar h h hea eart esion. Two patients had supravalvular AS and 5 had subaortic stenosis due to tunnel/ridge and we were re re e e ex xc xclu lu lude de ded, d l lea ea eav ving 1,704 included in the an nal al aly ys sis.
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Atrial Fibrillation
Patients with atrial fibrillation were older, had higher resting heart rate, higher prevalence of symptoms, and more commonly had a history of previous heart failure episodes compared to patients without atrial fibrillation (Table 4) . Additionally, patients with atrial fibrillation had a slightly lower ejection fraction, lower systemic arterial compliance, higher E/e' ratio, higher right ventricular systolic pressure and a larger left atrial volume compared to those without atrial fibrillation.
Survival by Flow Gradient Pattern
Mean follow-up duration was 2.3±1.9 years (limits 0-6.9 years). Overall, 1,057 (62%) patients had surgical AVR, and 64 (4%) patients had transcatheter AVR. NF/LG patients had the lowest rate of AVR with 2 year survival free of AVR 59% (95% CI 53%-65%).
Patients with LF/LG had the highest all-cause mortality of all groups (Figure 1) . Overall 2 year survival in the LF/LG group was 60% vs. 85% in the NF/LG group, 82% in the NF/HG with NF groups (26% vs. 7% and 5%, p<0.0001).
Atrial Fibrillation
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Predictors of Mortality
Multivariable Cox proportional hazards regression analysis using inverse probability weights identified age, male sex, obesity, hypertension, history of heart failure, aortic valve area, ejection fraction, and flow-gradient pattern to be associated with all-cause mortality ( Table 5 ). The presence of symptoms at baseline was not associated with mortality in any of the 4 groups (Figure 4) . Overall, AVR was associated with a 69% reduction in the risk of death (HR 0.31, 95% CI 0.25-0.39, p<0.0001). Concomitant coronary artery bypass grafting was not associated with mortality (p=0.66). There was evidence of a difference in the effect of AVR between flowgradient pattern groups (p<0.001). AVR conferred a strong survival benefit in LF/LG and NF/HG patients, whereas there was no survival benefit from AVR in the NF/LG and LF/HG groups. There was a trend towards NF/HG deriving more survival benefit from AVR than LF/LG patients (p=0.08).
Discussion
To date this study represents the largest analysis of characteristics and outcomes according to flow-gradient patterns in patients with AVA < 1cm 2 and preserved EF, providing new insights into pathophysiology, prevalence, and clinical outcomes in AS.
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Ove era ra ral ll ll, , AVR was associated with a a a 69 69 6 % % reduction in n n the e r r ris is isk k of death (HR 0.31, patients with AVA < 1 cm 2 and preserved EF; these included only 3% with LF/LG and 21% with NF/LG. LF/LG was associated with reduced survival compared to all other groups. In contrast, patients with NF/LG had better survival with medical management compared to NF/HG. In fact, the NF/LG pattern was an independent predictor of survival after multivariable analysis, demonstrating that NF/LG is a marker of lower risk. AVR was associated with excellent survival across all flow-gradient patterns, and after multivariable analysis there was evidence of a difference in the effect of AVR among groups. Both LF/LG and NF/HG groups had a survival benefit from AVR, whereas NF/LG had no observed survival advantage from AVR. These data have important implications for the assessment and management of patients with AS, and underscore the need to revise current definitions of AS severity.
Clinical Implications
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Afterload measures (Zva, SAC and SVR) were uniformly abnormal in LF compared to NF. Zva, an indirect measure of global LV afterload, was lower in LF/LG compared to the LF/HG group, a result of higher mean aortic valve gradient in the LF/HG group in the setting of similar blood pressure and stroke volume. The LF/LG group had the lowest SAC and highest SVR, indicating increased vascular stiffness and peripheral resistance. Reduced SAC is common in AS and is associated with LV systolic and diastolic dysfunction 7 . Additionally after multivariable analysis, systemic hypertension, a disease associated with abnormal arterial properties, was independently associated with mortality.
Atrial fibrillation was more common in the LF groups compared with the NF groups, with 22 and 26% prevalence in the LF/HG and LF/LG groups, respectively, versus 7% of NF/LG and 6% of NF/HG groups at the time of echocardiographic assessment (p<0.0001). For patients in atrial fibrillation, 10 cardiac cycles were averaged to obtain stroke volume and mean transvalvular aortic pressure gradient; it is unlikely that differences in flow and gradient were a result of error due to variable cycle lengths in atrial fibrillation. In atrial fibrillation, atrial contribution to LV filling in late diastole diminishes and diastolic filling time is shortened by increased heart rate resulting in reduced stroke volume. Additionally, the presence of atrial fibrillation may serve as a marker of more advanced diastolic dysfunction and left atrial hypertension resulting from comorbidities such as coronary artery disease, obesity, and diabetes which were more common in LF groups. These mechanisms are supported by the higher resting heart rate, LV filling pressures, left atrial volume and right ventricular systolic pressure observed in patients with atrial fibrillation.
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The prevalence of flow gradient patterns found in this study is similar to a recent study by Valves) trial showed that one third of patients with preserved EF had low flow at baseline, which may be related to the higher prevalence of advanced cardiovascular and pulmonary disease in the highly selected group of patients entered into the trial 15 .
Our data also provide new insights into the pathophysiology of LF/HG AS. The LF in the LF/HG group is affected by increased body surface area and driven primarily by excess weight and BMI (nearly 80% were obese).The average absolute stroke volume of this group was 70 mL, which would not be considered LF in a patient with normal body surface area. The 
Exclusion of Concomitant Valvular Lesions
Concomitant valvular heart disease can result in reduced forward LV stroke volume, resulting in a state of LF. For this reason, patients with moderate valvular stenosis or regurgitation were excluded, similar to other previous investigations 4, 16 . In contrast, some studies have not excluded these patients 2, 9 , raising the possibility that the etiology of reduced flow in these reports may be different from that of paradoxical LF/LG severe AS described as a combination of small LV cavity, intrinsic myocardial dysfunction, and increased arterial afterload 17 . Without correcting for valvular causes of reduced stroke volume, the relative prevalences of LF would be much higher (41% of patients that initially met inclusion criteria in our study were excluded for moderate concomitant valvular lesions), which may in part explain the lower prevalence of LF in our study.
Stroke Volume Assessment
The lower observed prevalence of LF/LG severe AS in the present study compared with previous studies may also be explained in part by differing methodologies. First, the present study represents a large group of consecutive AS patients regardless of symptom status and subsequent management. Secondly, the method of LV outflow tract diameter measurement at our institution differs from the European Society of Echocardiography/ American Society Echocardiography guidelines in that we measure the LV outflow tract diameter at the level of aortic cusp insertion 18 rather than "5 to 10 mm below the aortic valve orifice." We believe this method may have greater reproducibility, although this has not been proven. A study by Poh and colleagues using 3-D echocardiography has illustrated why measuring LV outflow tract diameter at a variable correcting for valvular causes of reduced stroke volume, the relative prevalences s of of f L LF F F wo wo woul ul uld d d be much higher (41% of patients that initially met inclusion criteria in our study were excluded for m m mod od ode er erat at ate e e co co onc com om omitant valvular lesions), which h h m m may in part expl pl lai a n th th he e e lower prevalence of LF n n o o our u study.
St Stro ro roke ke ke V Vol ol olum um u e e As Asse ses s ssm me ment t t
The lower ob bse se serv rv r ed ed ed p p pre re reva v v le le lenc nc nce e of of of L L LF/ F F LG LG LG s sev ev ever er ere e AS AS AS i in n th th the e e pr pr pres es esen en e t st st s ud ud udy y y co co comp mp par ar ared ed ed w w with previou u us distance below the annulus can lead to wide variation in measurements 19 . Additionally, our laboratory systematically measures peak aortic valve velocity in multiple imaging windows in order to obtain the peak signal, which may yield a higher prevalence of HG AS and reduce the prevalence of LG AS due to measurement error from inability to detect the peak velocity.
Limitations
This investigation represents the largest consecutive population of AS patients characterized by flow-gradient patterns using comprehensive echocardiography evaluation studied to date, although its retrospective nature is an inherent limitation. There may be features of the patient groups, not accounted for in our study, which contributed to differences in outcomes. Although biplane LV volume data was not available, a subgroup analysis of patients with similar stroke volume measurements using LV dimensions showed close agreement in flow-gradient pattern prevalences with the overall group. Nevertheless, it is possible that the prevalence of LF and LF/LG were underestimated in the study. Our study is unique in that it provides insight into the prevalence, demographics, characteristics and clinical outcomes of the various flow-gradient patterns using a systematic AS measurement methodology that is consistently performed at our institution. Finally, unindexed aortic valve area as opposed to indexed valve area, was used to define AS severity; this may have resulted in larger differences in BMI between groups, potentially contributing to differences in outcomes.
Conclusions
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